Healthcare
Utah Medical Products, Inc.(UTMD)
Live Price
Offline$67.84
-2.30% today
1Y Change
+19.69%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- $210.00M
- Revenue Growth
- -5.8%
- EPS Growth
- -13.9%
- Dividend Yield
- 1.9%
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Utah Medical Products, Inc. (UTMD) is a Healthcare stock with a market cap of $210.00M and listed on NASDAQ. The stock last traded around $67.84 and up 19.7% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -5.8%, EPS growth of -13.9%, a dividend yield of 1.9%. What stands out right now is revenue -5.8%, EPS -13.9%, free cash flow -1.9% with operating margin 28.8% and ROIC 7.2%. The dividend is present but secondary, with a yield around 1.9%. Valuation sits in the middle of the pack at P/E 19.3 and price/sales 5.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines UTMD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-5.8% vs +7.6% peer median
Operating Margin
Above sector median
+28.8% vs +19.4% peer median
P/E
Below sector median
19.3 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 28, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -5.8% and EPS is at -13.9%, with operating margin around 28.8%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.9%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.3% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 28, 2026 | โ | -2.4% | -2.6% | -1.6% |
2026 Jan 29, 2026 | โ | -1.0% | +2.0% | +8.0% |
2025 Oct 23, 2025 | โ | -0.0% | -6.4% | -11.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UTMD
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
UTMD Max Drawdown
-15.77%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for UTMD and SPY.
Company Overview
Utah Medical Products, Inc.
NASDAQ Global Select
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
- Leadership
- Kevin L. Cornwell
- IPO Date
- Mar 8, 1999
- Employees
- 155
- Street Address
- 7043 South 300 West
- Mailing
- Midvale, UT, 84047-1048
- Region
- Midvale, UT, US
- Reporting Currency
- USD
- Investor Line
- 801 566 1200
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 19.3
- EV/EBITDA
- 8.1
- Price/Sales
- 5.6
- Price/Book
- 1.7
Growth
- Revenue
- -5.8%
- EPS
- -13.9%
- Free Cash Flow
- -1.9%
Profitability
- Gross Margin
- 53.6%
- Operating Margin
- 28.8%
- Net Margin
- 28.9%
- ROE
- 9.1%
- ROIC
- 7.2%
Balance Sheet
- Debt/Equity
- 0.00
- Current Ratio
- 28.64
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.